Skip to main content
SpringerLink
Log in

Epidemiology of Prostate Cancer

  • Chapter
Prostate Cancer

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 175))

Abstract

Prostate cancer is one of the most important cancers in men. With a worldwide incidence of 25.3 per 100,000 it is the second most common cancer in men, with large differences between countries. Important clues on risk factors remain to be found. Age, genetic factors and environmental influences have been studied. Incidence has been increasing over the last few decades, largely due to early detection procedures. The mortality rate of 8.1 per 100,000 mainly affects men at older ages; increases in this rate over time and differences between countries are markedly smaller than for incidence. For the future, prostate cancer will remain an important and—through evolutions in incidence and demography—growing health problem.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Baquet CR, Horm JW, Gibb T, Greenwald P (1991) Socioeconomic factors and cancer incidence among blacks and whites. J Natl Cancer Inst 83:551–557

    Article  PubMed  CAS  Google Scholar 

  • Boyle P, Ferlay J (2005) Cancer incidence and mortality in Europe. Ann Oncol 6:481–488

    Article  Google Scholar 

  • Cancel-Tassin G, Cussenot O (2005) Prostate cancer genetics. Minerva Urol Nefrol 57:289–300

    PubMed  CAS  Google Scholar 

  • Coebergh JW, Janssen-Heijnen ML, Post PN, Razenberg PP (1999) Serious co-morbidity among unselected cancer patients newly diagnosed in the southeastern part of The Netherlands. J Clin Epidemiol 52:1131–1136

    Article  PubMed  CAS  Google Scholar 

  • Coleman MP, Gatta G, Verdecchia A, Estève J, Sant M, Storm H, Allemani C, Ciccolallo L, Santaquilani M, Berrino F, et al (2003) Eurocare-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol 14:v128–v149

    Article  PubMed  Google Scholar 

  • Denis L, Morton MS, Griffiths K (1999) Diet and its preventive role in prostatic disease. Eur Urol 35:377–387

    Article  PubMed  CAS  Google Scholar 

  • Ferlay J, Bray F, Pisani P, Parkin DM (2004) Globocan 2002: cancer Incidence, mortality and prevalence worldwide. IARC CancerBase No. 5. version 2.0. IARC Press, Lyon. http://www-dep.iarc.fr. Cited 22 Sept 2006

    Google Scholar 

  • Gennigens C, Menetrier-Caux C, Droz JP (2005) Insulin like growth factor (IGF) family and prostate cancer. Crit Rev Oncol hematol 58:124–145

    Google Scholar 

  • Grönberg H, Damber L, Damber JE (1994) Studies of genetic factors in prostate cancer in a twin population. J Urol 52:1484–1487

    Google Scholar 

  • Grönberg H, Damber L, Damber JE (1996) Total food consumption and the Body mass index in relation to prostate cancer risk: a case-control study in Sweden with prospectively collected exposure data. J Urol 155:969–970

    Article  PubMed  Google Scholar 

  • Grönberg H, Damber L, Jonson H, Damber JE (1997) Prostate cancer mortality in Northern Sweden, with special reference to tumor grade and patient age. J Urol 49:374–378

    Article  Google Scholar 

  • Hanchette CL, Schwartz GG (1992) Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 70:2861–2869

    Article  PubMed  CAS  Google Scholar 

  • Houterman S, Janssen-Heijnen ML, Hendrikx AJ, Berg HA, Coebergh JW (2005) Impact of comorbidity on treatment and prognosis of prostate cancer patients: a population basedstudy. Crit rev Oncol hematol 58:60–67

    PubMed  Google Scholar 

  • Hsing AW, Tsao L, Devesa SS (1999) International trends and patterns of prostate cancer incidence and mortality. Int J Cancer. Ann Oncol 85:60–67

    Article  Google Scholar 

  • Levi F, Luccini F, Negri E, Boyle P, La Vecchia C (2004) Leveling of prostate cancer mortality in western Europe. Prostate 60:46–52

    Article  PubMed  Google Scholar 

  • Magee PJ, Rowland IR (2004) Phyto-oestrogens, their mechanism of action:current evidence for a role in breast and prostate cancer. Br J Nutr 91:513–531

    Article  PubMed  CAS  Google Scholar 

  • Mettlin C (2000) Impact of screening on prostate cancer rates and trends. Microsc Res Tech 51:415–418

    Article  PubMed  CAS  Google Scholar 

  • Naber KG, Lobel B, Weidner W, Algaba F, Prezioso D, Denis LJ, Griffiths K (2004) Further insights into endocrine disease, the enigma of prostatitis. An IPHC Teaching Programme. IPHC, Jan 2004

    Google Scholar 

  • National Cancer Institute (2006) Genetics of prostate cancer. http://www.nci.nih.gov/cancertopics/pdq/genetics/prostate. Cited 22 Sept 2006

    Google Scholar 

  • Newcomer LM, Stanford JL, Blumenstein BA, brawer MK (1997) Temporal trends in rates of prostate cancer: declining incidence of advanced stage disease. J Urol 158:1427–1430

    Article  PubMed  CAS  Google Scholar 

  • Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics. CA Cancer J Clin 55:74–108

    Article  PubMed  Google Scholar 

  • Parsons JK, Carter HB, Platz EA, Wright EJ, Landis P, Metter EJ (2005) Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy. Cancer Epidemiol Biomarkers Prev 14:2257–2260

    Article  PubMed  CAS  Google Scholar 

  • Pienta KJ, Esper PS (1993) Risk factors for prostate cancer. Ann Intern Med 118:793–803

    PubMed  CAS  Google Scholar 

  • Polek TC, Weigel NL (2002) Vitamin D and prostate cancer. J Androl 23:9–17

    PubMed  CAS  Google Scholar 

  • Prezioso D, Denis LJ, Klocker H, Sciarra A, Reis M, Naber K, lobel B, Pacik D, Griffiths K (2004) Further insights into endocrine disease, oestrogens and the prostate gland. An IPHC Teaching Programme. IPHC, Jan 2004

    Google Scholar 

  • Quinn M, Babb P (2002) Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: International comparisons. BJU Int 90:162–173

    Article  PubMed  CAS  Google Scholar 

  • Quinn MJ, d’Onofrio A, Moller B, et al (2003) Cancer mortality trends in EU and acceding countries. Ann Oncol 14:1148–1152

    Article  PubMed  CAS  Google Scholar 

  • Rosenblatt KA, Wicklund KG, Stanford JL (2001) Sexual factors and the risk of prostate cancer. Am J Epidemiol 153:1152–1158

    Article  PubMed  CAS  Google Scholar 

  • Sant M, Aereleid T, berrino F, Bielska Lasota M, Carli PM, Faivre J, Grosclaude P, Hédelin G, Matsuda T, Møller H, Möller T, Verdecchia A, Capocaccia R, Gatta G, Micheli A, Santaquilani M, Roazzi P; the Eurocare working group (2003) Eurocare-3 summary: survival of cancer patients diagnosed 1990–94—results and commentary. Ann Oncol 14(Suppl 5):v61–v118

    Article  PubMed  Google Scholar 

  • Schröder FH, Denis LJ, Roobol M, et al (2003a) The story of the European randomized study of screening for prostate cancer. BJU Int 92Suppl 2:1–13

    Article  PubMed  Google Scholar 

  • Schröder FH, Albertsen P, Boyle P, Candas B, Catalona AW, Cheng C, De Koning HJ, Fourcade R, Hugosson J, Moul J, Perrin P, Roehrborn C, Rübben H, Stephenson R, Yamanaka H (2003b) Early detection and screening for prostate cancer. In: Bartsch DK, Khoury S, Murai M, Partin A (eds) Prostate cancer. Proceedings of the 3rd International Consultation on Prostate Cancer, Paris, 21–23 June 2003; pp 19–47

    Google Scholar 

  • Sim HG, Cheng CW (2005) Changing demography of prostate cancer in Asia. Eur j cancer 41:834–845

    Article  PubMed  Google Scholar 

  • Sonn GA, Aronson W, Litwin MS (2005) Impact of diet on prostate cancer: a review. Prostate cancer prostatic dis 8:304–310

    Article  PubMed  CAS  Google Scholar 

  • Stanford JL, Damber JE, Fair WR, Sancho-Garnier H, Griffiths K, Gu FL, Kiemeney LA (1999) Epidemiology of prostate cancer. In: Murphy G, Khoury S, Partin A, Denis L (eds) Prostate cancer. Proceedings of the 2nd International Consultation on Prostate Cancer. Plymbridge Distributors, Plymouth, pp 23–55

    Google Scholar 

  • Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC (1990) Family history and the risk of prostate cancer. Prostate 17:337–347

    Article  PubMed  CAS  Google Scholar 

  • Surveillance, Epidemiology, and End Results Program (2006) SEER cancer statistics review, 1975–2002. Bethesda: National Cancer Institute. http://seer.cancer.gov/cgi-bin/csr/1975_2002. Cited 22 Sept 2006

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Public Health Department, Provinciaal Instituut voor Hygiëne, Kronenburgstraat 45, 2000, Antwerp, Belgium

    Vera Nelen MD

Authors
  1. Vera Nelen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Chaim Sheba Medical Center, Tel-Hashomer, Ramat-Gan, 52621, Israel

    Jacob Ramon MD

  2. Lange Gasthuisstraat 35-37, 2000, Antwerp, Belgium

    Louis J. Denis MD, FACS (Director Oncology Centre Antwerp Secretary Europa Uomo) (Director Oncology Centre Antwerp Secretary Europa Uomo)

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Nelen, V. (2007). Epidemiology of Prostate Cancer. In: Ramon, J., Denis, L.J. (eds) Prostate Cancer. Recent Results in Cancer Research, vol 175. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-40901-4_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-40901-4_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-40897-0

  • Online ISBN: 978-3-540-40901-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation